Articles
Low-dose aspirin and stroke. "It ain't necessarily so"
ML Dyken, HJ Barnett, JD Easton, WS Fields, V Fuster, V Hachinski, JW Norris, and DG Sherman
| You have reached the most complete version of this article accessible without further authentication.
More complete versions are available. Link to article |
Article topics:
- Pharmacology..Heart Diseases (Drug Development)
- Neuroscience..Cerebrovascular Accident
- Medicine..Scientific Councils
- Medicine..Research Personnel
- Medicine..Infarction
- Medicine..Clinical Trials
- Medicine..Myocardial Infarction
- Medicine..Stroke Prevention
This article has been cited by other articles:
 |
|
 |
|
  D. J.H. McCabe, P. Harrison, S. J. Machin, H. Watt, M. M. Brown, and M. J. Alberts Measurement of the Antiplatelet Effects of Aspirin in Cerebrovascular Disease * Response Stroke, June 1, 2004; 35(6): e146 - e147. [Full Text] [PDF]
|
|
|
|
 |
|
 K. Asplund Review: antiplatelet treatment prevents occlusive vascular events in high risk patients Evid. Based Med., July 1, 2002; 7(4): 110 - 110. [Full Text] [PDF]
|
|
|
|
 |
|
 A. T. Collaboration Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients BMJ, January 12, 2002; 324(7329): 71 - 86. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Catella-Lawson Vascular biology of thrombosis: Platelet-vessel wall interactions and aspirin effects Neurology, September 1, 2001; 57(90002): S5 - 7. [Abstract] [Full Text]
|
|
|
|
 |
|
 E. H. Awtry and J. Loscalzo Aspirin Circulation, March 14, 2000; 101(10): 1206 - 1218. [Full Text] [PDF]
|
|
|
|
|
|
G. W. Albers, R. G. Hart, H. L. Lutsep, D. W. Newell, and R. L. Sacco Supplement to the Guidelines for the Management of Transient Ischemic Attacks : A Statement From the Ad Hoc Committee on Guidelines for the Management of Transient Ischemic Attacks, Stroke Council, American Heart Association Stroke, November 1, 1999; 30(11): 2502 - 2511. [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Wilterdink and J. D. Easton Dipyridamole Plus Aspirin in Cerebrovascular Disease Arch Neurol, September 1, 1999; 56(9): 1087 - 1092. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. B. Gorelick, G. V. R. Born, R. B. D'Agostino, D. F. Hanley Jr, L. Moye, and C. J. Pepine Therapeutic Benefit : Aspirin Revisited in Light of the Introduction of Clopidogrel Stroke, August 1, 1999; 30(8): 1716 - 1721. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. S. Johnson, S. F. Lanes, C. E. Wentworth III, M. H. Satterfield, B. L. Abebe, and L. W. Dicker A Metaregression Analysis of the Dose-Response Effect of Aspirin on Stroke Arch Intern Med, June 14, 1999; 159(11): 1248 - 1253. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Bednar and C. E. Gross Antiplatelet Therapy in Acute Cerebral Ischemia Stroke, April 1, 1999; 30(4): 887 - 893. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. S. Treiman The Natural History of Asymptomatic Carotid Stenosis: Assessing the Risk and Rate of Disease Progression Perspectives in Vascular Surgery and Endovascular Therapy, January 1, 1999; 11(2): 95 - 109. [Abstract] [PDF]
|
|
|
|
|
|
P. B. Gorelick and D. F. Hanley Jr Clopidogrel and Its Use in Stroke Patients Stroke, August 1, 1998; 29(8): 1737 - 1737. [Full Text] [PDF]
|
|
|
|
|
|
J. Biller, W. M. Feinberg, J. E. Castaldo, A. D. Whittemore, R. E. Harbaugh, R. J. Dempsey, L. R. Caplan, T. F. Kresowik, D. B. Matchar, J. F. Toole, et al. Guidelines for Carotid Endarterectomy : A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association Circulation, February 10, 1998; 97(5): 501 - 509. [Full Text] [PDF]
|
|
|
|
|
|
F. Masuhr, M. Busch, and K. M. Einhaupl Differences in Medical and Surgical Therapy for Stroke Prevention Between Leading Experts in North America and Western Europe Stroke, February 1, 1998; 29(2): 339 - 345. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Biller, W. M. Feinberg, J. E. Castaldo, A. D. Whittemore, R. E. Harbaugh, R. J. Dempsey, L. R. Caplan, T. F. Kresowik, D. B. Matchar, J. F. Toole, et al. Guidelines for Carotid Endarterectomy : A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association Stroke, February 1, 1998; 29(2): 554 - 562. [Full Text] [PDF]
|
|
|
|
|
|
C. H. Hennekens, M. L. Dyken, V. Fuster, and V. Fuster Aspirin as a Therapeutic Agent in Cardiovascular Disease : A Statement for Healthcare Professionals From the American Heart Association Circulation, October 21, 1997; 96(8): 2751 - 2753. [Full Text]
|
|
|
|
|
|
C. M. Helgason and P. A. Wolf American Heart Association Prevention Conference IV: Prevention and Rehabilitation of Stroke : Introduction Stroke, July 1, 1997; 28(7): 1498 - 1500. [Full Text]
|
|
|
|
|
|
L. B. Goldstein, A. Farmer, and D. B. Matchar Primary Care Physician–Reported Secondary and Tertiary Stroke Prevention Practices : A Comparison Between the United States and the United Kingdom Stroke, April 1, 1997; 28(4): 746 - 751. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. Szczeklik, J. Musial, A. Undas, J. Swadzba, P. F. Gora, W. Piwowarska, and M. Duplaga Inhibition of Thrombin Generation by Aspirin Is Blunted in Hypercholesterolemia Arterioscler. Thromb. Vasc. Biol., August 1, 1996; 16(8): 948 - 954. [Abstract] [Full Text]
|
|
|
|
|
|
R. G. Hart and M. J.G. Harrison Aspirin Wars : The Optimal Dose of Aspirin to Prevent Stroke Stroke, April 1, 1996; 27(4): 585 - 587. [Full Text]
|
|
|
|
|
|
C. Patrono and G. J. Roth Aspirin in Ischemic Cerebrovascular Disease : How Strong Is the Case for a Different Dosing Regimen? Stroke, April 1, 1996; 27(4): 756 - 760. [Abstract] [Full Text]
|
|
|
|
|
|
L. B. Goldstein, A. J. Bonito, D. B. Matchar, P. W. Duncan, G. H. DeFriese, E. Z. Oddone, J. E. Paul, D. R. Akin, and G. P. Samsa US National Survey of Physician Practices for the Secondary and Tertiary Prevention of Ischemic Stroke : Design, Service Availability, and Common Practices Stroke, September 1, 1995; 26(9): 1607 - 1615. [Abstract] [Full Text]
|
|
|
|
|
|
P. B. Gorelick Stroke Prevention Arch Neurol, April 1, 1995; 52(4): 347 - 355. [Abstract] [PDF]
|
|
|
|
 |
|
 J. H. Vial and C. Narkowicz Comparison of Cyclooxygenase Inhibition with Two Different Doses of Enteric Coated Aspirin in Normal Young and Elderly Subjects and Elderly with Cerebrovascular Disease Clinical and Applied Thrombosis/Hemostasis, January 1, 1995; 1(1): 55 - 61. [Abstract] [PDF]
|
|
|
|
 |
|
 C. Patrono Aspirin as an Antiplatelet Drug N. Engl. J. Med., May 5, 1994; 330(18): 1287 - 1294. [Full Text]
|
|
|
|
|
|
J. W. Eikelboom, J. Hirsh, J. I. Weitz, M. Johnston, Q. Yi, and S. Yusuf Aspirin-Resistant Thromboxane Biosynthesis and the Risk of Myocardial Infarction, Stroke, or Cardiovascular Death in Patients at High Risk for Cardiovascular Events Circulation, April 9, 2002; 105(14): 1650 - 1655. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||